Related Experiment Video
Updated: Apr 17, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
IL-6 promoter functional polymorphism -572C/G affects spontaneous clearance of hepatitis B virus infection
Background:
Recent research has shown the host innate immunity plays important roles in controlling HBV infec- tion, and interleukin-6 (IL-6) is the key factor involved in the innate immune response. It is well known that the polymorphisms of IL-6 promoter can affect both the transcription and production of IL-6. This study aims to investigate whether there is an association between the IL-6 promoter functional polymorphisms and spontaneous clearance of HBV.
Methods:
Two polymorphisms of the IL-6 gene, -572 C/G (rs1800796) and -597 G/A (rs1800797), were analyzed by DNA sequencing in a case-control study including 219 cases with chronic HBV infection and 212 controls spontaneously recovered from HBV infection.
Results:
For IL-6 -572 C/G, the controls with spontaneous clearance of HBV have significantly higher allele G (0.302 vs. 0.21, p = 0.002) and GG genotype frequency (0.075 vs. 0.032, p = 0.006) compared to the chronic HBV infection patients. The odds ratio (OR) for the G allele was 0.61 (95% confidence interval [CI]: 0.45-0.84). For -597 G/A, all subjects are GG genotype except one GA genotype in the recovered controls, no significant differences in allele or genotype frequencies between the case group and control group were observed.
Conclusions:
These findings indicate that the IL-6 -572 allele G may be beneficial for spontaneous clearance of HBV.
More Related Videos
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu